Help Patients Overcome Medication Access Barriers

We've saved patients nearly $10M in prescription costs.

Breaking Down Medication Access Barriers Medication access barriers can often hinder brands from achieving their potential market share. Often, these barriers can lead to the prescribing of alternative medications or even prescription abandonment, ultimately impacting patients' access to appropriate and critical therapy. Learn how our solutions help mitigate barriers by accessing our new Technology Solutions Overview »   Affordability We've saved patients nearly $10M in prescription costs through our affordability solution, driving a 30% adherence rate.1*   Prior Authorization (PA) With enhanced PA support, the number of health plan determination approvals nearly doubles, helping more patients obtain their prescribed therapy due to more PA requests making it through to the plan.1   Patient Support Services Streamlined processes and support services, accessed through a single platform, enable a decrease in time to therapy by as much as 34%.1,2 With technology at our core and the industry's largest network, CoverMyMeds' suite of solutions provides reliable support to overcome medication access challenges when your brand is prescribed. Our digital solutions help decrease time to therapy for patients and create a seamless end-to-end journey for providers and pharmacists. Explore how we can help mitigate medication access barriers in our new Technology Solutions Overview. ACCESS THE OVERVIEW To learn more about CoverMyMeds and how our solutions solve patient medication access challenges, visit covermymeds.com. 1. CoverMyMeds data on file, 2020. 2. The Impact of Disease-Modifying Therapy Acccess Barriers on People With Multiple Sclerosis: Mixed-Methods Study, Journal of Medical Internet Research,2018 *Representative of one program. Not representative of all programs.

Want to reach 64,000+ biopharma industry executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of Industry Dive, Inc. 1575​ Eye St NW, Suite 400, Washington,​ DC 20005